Asprosin serum levels and glucose homeostasis in children with obesity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asprosin serum levels and glucose homeostasis in children with obesity
Authors
Keywords
Decreased asprosin levels, Childhood obesity, Insulin resistance, Body mass index, Oral glucose tolerance test
Journal
CYTOKINE
Volume 142, Issue -, Pages 155477
Publisher
Elsevier BV
Online
2021-03-02
DOI
10.1016/j.cyto.2021.155477
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased Serum Circulating Asprosin Levels in Children with Obesity
- (2020) Eda Sünnetçi Silistre et al. PEDIATRICS INTERNATIONAL
- Precocious Preclinical Cardiovascular Sonographic Markers in Metabolically Healthy and Unhealthy Childhood Obesity
- (2020) Domenico Corica et al. Frontiers in Endocrinology
- Saliva and Blood Asprosin Hormone Concentration Associated with Obesity
- (2019) Kader Ugur et al. International Journal of Endocrinology
- Case Reports of Pre-clinical Replication Studies in Metabolism and Diabetes
- (2019) Matthias von Herrath et al. Cell Metabolism
- Asprosin attenuates insulin signaling pathway through PKCδ‐activated ER stress and inflammation in skeletal muscle
- (2019) Tae Woo Jung et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Asprosin impairs insulin secretion in response to glucose and viability through TLR4/JNK-mediated inflammation
- (2019) Taeseung Lee et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Decreased Circulating Levels of Asprosin in Obese Children
- (2019) Wenjun Long et al. Hormone Research in Paediatrics
- Asprosin improves the survival of mesenchymal stromal cells in myocardial infarction by inhibiting apoptosis via the activated ERK1/2-SOD2 pathway
- (2019) Zhengbin Zhang et al. LIFE SCIENCES
- Serum Asprosin Concentrations Are Increased and Associated with Insulin Resistance in Children with Obesity
- (2019) Min Wang et al. ANNALS OF NUTRITION AND METABOLISM
- Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths
- (2019) Domenico Corica et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Increased serum level and impaired response to glucose fluctuation of asprosin is associated with type 2 diabetes mellitus
- (2019) Xinyue Zhang et al. Journal of Diabetes Investigation
- Does Family History of Obesity, Cardiovascular, and Metabolic Diseases Influence Onset and Severity of Childhood Obesity?
- (2018) Domenico Corica et al. Frontiers in Endocrinology
- Serum asprosin levels and bariatric surgery outcomes in obese adults
- (2018) Chao-Yung Wang et al. INTERNATIONAL JOURNAL OF OBESITY
- GW29-e0080 The protective role of Asprosin against diabetes in cardiomyocytes
- (2018) Jian Feng et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Asprosin is a centrally acting orexigenic hormone
- (2017) Clemens Duerrschmid et al. NATURE MEDICINE
- Circulating asprosin concentrations are increased in type 2 diabetes mellitus and independently associated with fasting glucose and triglyceride
- (2017) Lei Zhang et al. CLINICA CHIMICA ACTA
- Asprosin, a Fasting-Induced Glucogenic Protein Hormone
- (2016) Chase Romere et al. CELL
- Childhood Obesity, Other Cardiovascular Risk Factors, and Premature Death
- (2010) Paul W. Franks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tracking of childhood overweight into adulthood: a systematic review of the literature
- (2008) A. S. Singh et al. Obesity Reviews
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation